The use of therapeutic peptides to target and to kill cancer cells
Boohaker, R J, Lee, M W, Vishnubhotla, P, Perez, J M, Khaled, A R
Published in Current medicinal chemistry (01.01.2012)
Published in Current medicinal chemistry (01.01.2012)
Get more information
Journal Article
The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption
Lee, M W, Bassiouni, R, Sparrow, N A, Iketani, A, Boohaker, R J, Moskowitz, C, Vishnubhotla, P, Khaled, A S, Oyer, J, Copik, A, Fernandez-Valle, C, Perez, J M, Khaled, A R
Published in Cell death & disease (22.05.2014)
Published in Cell death & disease (22.05.2014)
Get full text
Journal Article
Abstract P6-04-13: Preclinical testing using a novel CT20p peptide-nanoparticle combination in breast cancer
Vishnubhotla, PS, Boohaker, RJ, Lee, MW, Nemec, KN, Santra, S, Khaled, AS, Perez, M, Khaled, AR
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article